
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
Imran Howell, Aleksandra Howell, Ian Pavord
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 7
Open Access | Times Cited: 28
Imran Howell, Aleksandra Howell, Ian Pavord
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 7
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Type 2 immunity in allergic diseases
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 6
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 6
TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
Pauline Schmitt, Anais Dufros Duval, M. Camus, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 9
Pauline Schmitt, Anais Dufros Duval, M. Camus, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 9
Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification
Joseph Jorssen, Glenn Van Hulst, Kiréna Mollers, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1549-1566.e8
Closed Access | Times Cited: 9
Joseph Jorssen, Glenn Van Hulst, Kiréna Mollers, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1549-1566.e8
Closed Access | Times Cited: 9
Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell
Simone E. M. Olsthoorn, Anneloes van Krimpen, Rudi W. Hendriks, et al.
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Simone E. M. Olsthoorn, Anneloes van Krimpen, Rudi W. Hendriks, et al.
Immunological Reviews (2025) Vol. 330, Iss. 1
Open Access | Times Cited: 1
Eosinophilic mucus diseases
Misaki Arima, Keisuke Ito, Tomoe Abe, et al.
Allergology International (2024) Vol. 73, Iss. 3, pp. 362-374
Open Access | Times Cited: 6
Misaki Arima, Keisuke Ito, Tomoe Abe, et al.
Allergology International (2024) Vol. 73, Iss. 3, pp. 362-374
Open Access | Times Cited: 6
Impact of obesity in asthma: Possible future therapies
Hiroki Tashiro, Yuki Kurihara, Yuki Kuwahara, et al.
Allergology International (2023) Vol. 73, Iss. 1, pp. 48-57
Open Access | Times Cited: 12
Hiroki Tashiro, Yuki Kurihara, Yuki Kuwahara, et al.
Allergology International (2023) Vol. 73, Iss. 1, pp. 48-57
Open Access | Times Cited: 12
Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases
Limei Cui, Yujuan Yang, Hao Yan, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Limei Cui, Yujuan Yang, Hao Yan, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
The Link Between Respiratory Syncytial Virus–Induced Lower Respiratory Tract Infection and Type 2 Inflammation in Asthma
Ye Bei, Shu Teng, Lu Zhan
Clinical Pediatrics (2025)
Closed Access
Ye Bei, Shu Teng, Lu Zhan
Clinical Pediatrics (2025)
Closed Access
Biologicals reduce drug burden and improve physical and mental health in severe eosinophilic asthma
Vincenzo Patella, Roberta Zunno, Girolamo Pelaia, et al.
Journal of Asthma (2025), pp. 1-6
Closed Access
Vincenzo Patella, Roberta Zunno, Girolamo Pelaia, et al.
Journal of Asthma (2025), pp. 1-6
Closed Access
The clinical and pathological histology efficacy of biological therapy for severe asthma with a phenotype of type 2 inflammation - systematic review
Junhui Ma, Qiang Ma, Jing Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Junhui Ma, Qiang Ma, Jing Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Anti-inflammatory effects of oral prednisolone at stable state in people treated with mepolizumab: a proteomic and bulk transcriptomics analysis
Imran Howell, Freda Yang, Vanessa Brown, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Imran Howell, Freda Yang, Vanessa Brown, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
Karoline Strobl, Jörg Klufa, Regina Jin, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 12, pp. 3142-3168
Closed Access | Times Cited: 3
Karoline Strobl, Jörg Klufa, Regina Jin, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 12, pp. 3142-3168
Closed Access | Times Cited: 3
An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma
Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, et al.
Children (2024) Vol. 11, Iss. 7, pp. 843-843
Open Access | Times Cited: 2
Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, et al.
Children (2024) Vol. 11, Iss. 7, pp. 843-843
Open Access | Times Cited: 2
Lentinan attenuates allergic airway inflammation and epithelial barrier dysfunction in asthma via inhibition of the PI3K/AKT/NF-κB pathway
Yansha Song, Yu Chen, Hui Cai, et al.
Phytomedicine (2024) Vol. 134, pp. 155965-155965
Closed Access | Times Cited: 2
Yansha Song, Yu Chen, Hui Cai, et al.
Phytomedicine (2024) Vol. 134, pp. 155965-155965
Closed Access | Times Cited: 2
Neochlorogenic acid ameliorates allergic airway inflammation by suppressing type 2 immunity and upregulating HO-1 expression
Shu‐Chen Cheng, Chian‐Jiun Liou, Shu‐Ju Wu, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113867-113867
Closed Access | Times Cited: 2
Shu‐Chen Cheng, Chian‐Jiun Liou, Shu‐Ju Wu, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113867-113867
Closed Access | Times Cited: 2
The epithelial era of asthma research: knowledge gaps and future direction for patient care
Christopher E. Brightling, Gianni Marone, Helena Aegerter, et al.
European Respiratory Review (2024) Vol. 33, Iss. 174, pp. 240221-240221
Open Access | Times Cited: 2
Christopher E. Brightling, Gianni Marone, Helena Aegerter, et al.
European Respiratory Review (2024) Vol. 33, Iss. 174, pp. 240221-240221
Open Access | Times Cited: 2
Differential drug response in pulmonary arterial hypertension: The potential for precision medicine
Elise Miller, Chinwuwanuju Ugo‐Obi Sampson, Ankit A. Desai, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 5
Elise Miller, Chinwuwanuju Ugo‐Obi Sampson, Ankit A. Desai, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 5
Type 2 severe asthma: pathophysiology and treatment with biologics
Corrado Pelaia, J. Mark Melhorn, Timothy S.C. Hinks, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 485-498
Closed Access | Times Cited: 1
Corrado Pelaia, J. Mark Melhorn, Timothy S.C. Hinks, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 485-498
Closed Access | Times Cited: 1
Hypersensitivity Reactions in the Respiratory Tract
Stefanie C.M. Burleson, Victor J. Johnson
Elsevier eBooks (2024)
Closed Access
Stefanie C.M. Burleson, Victor J. Johnson
Elsevier eBooks (2024)
Closed Access
Unrevealing the Gap: Fractional exhaled nitric oxide and clinical responsiveness to biological therapy in severe asthma - A retrospective study
Mauro Maniscalco, Claudio Candia, Dina Visca, et al.
ERJ Open Research (2024) Vol. 10, Iss. 5, pp. 00296-2024
Open Access
Mauro Maniscalco, Claudio Candia, Dina Visca, et al.
ERJ Open Research (2024) Vol. 10, Iss. 5, pp. 00296-2024
Open Access
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma
Imran Howell, Freda Yang, Vanessa Brown, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 5, pp. 1146-1158
Open Access
Imran Howell, Freda Yang, Vanessa Brown, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 5, pp. 1146-1158
Open Access
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
Xiaomu Wang, Yong Kong, Tianquan Qiu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113102-113102
Closed Access
Xiaomu Wang, Yong Kong, Tianquan Qiu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113102-113102
Closed Access
The role of DC subgroups in the pathogenesis of asthma
Jiangang Xu, Shuang Cao, Youhua Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jiangang Xu, Shuang Cao, Youhua Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The potential role of n-3 fatty acids and their lipid mediators on asthmatic airway inflammation
Yuan Tian, Jiping Sun, Diane Jiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Yuan Tian, Jiping Sun, Diane Jiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The effectiveness of vaccination against pneumococcal infection in patients with severe bronchial asthma
Г. Л. Игнатова, С. Н. Авдеев, В. Н. Антонов, et al.
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 11, pp. 1057-1062
Open Access
Г. Л. Игнатова, С. Н. Авдеев, В. Н. Антонов, et al.
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 11, pp. 1057-1062
Open Access